Thursday, July 30, 2026
12:00 pm - 1:00 pm CT/1:00 - 2:00 pm ET
Register
Description:
Join us for Part 2 of our Diagnostic Stewardship webinar series on UTI!
Patients presenting with altered mental status (AMS) are frequently treated for presumed urinary tract infection (UTI) based solely on urinalysis (UA) results, regardless of whether other localizing symptoms are present. These practices increase the risk of antibiotic-associated adverse drug events (ADEs), Clostridioides difficile infection, and antimicrobial resistance, while potentially delaying recognition of the true cause of AMS or respiratory symptoms.There are a variety of tools available to aid in diagnostic stewardship with a diverse degree of sophistication. Effective interventions range from education, to local policy change, to integrated EMR nudges, to statewide pay-for-performance initiatives.
This interprofessional education session will enhance participants’ understanding of diagnostic stewardship by exploring its clinical importance, outlining practical strategies for implementation, and examining real-world successes and challenges specific pneumonia. Participants will leave better equipped to collaborate across disciplines to optimize diagnostic practices and improve the appropriateness of testing and treatment decisions.
Agenda:
Following introductions, speakers will discuss four clinical trials with active learning occurring throughout. The session will end with attendee Q&A.
Target Audience: An interprofessional audience, specifically pharmacists and physicians, involved in the diagnosis and management of infectious diseases. The content may also apply to advanced practice providers, nurses, microbiologists, infection preventionists, and other healthcare professionals.
Learning Objectives:
- Describe the risks of misdiagnosis and overdiagnosis of asymptomatic bacteriuria
- Identify the strengths and weaknesses of diagnostic tests that are available to diagnose UTI
- Compare and contrast the sucesses and challenges associated with implementation of diagnostic stewardship interventions for asymptomatic bacteriuria
- Describe the role of pharmacists and physicians on the healthcare team to promote diagnostic and antimicrobial stewardship
Faculty:
Bradley J. Langford, PharmD, MPH
Antimicrobial Stewardship Pharmacist
Public Health Ontario
Toronto, Ontario Canada
Larissa Matukas, MD, FRCPC
Associate Professor, Department of Laboratory Medicine and Pathobiology
University of Toronto
Toronto, Ontario Canada
Accreditation:
Pharmacist
The Society of Infectious Diseases Pharmacists (SIDP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
UAN: 0672-0000-26-043-L99-P
CPE credit: 1.0 contact hour (0.1 CEU)
Type of activity: Application
Release date: July 30, 2026
ACPE Activity Fee: SIDP Member: Free / Non-Member: $10
To receive CE credit, participants must view the CE content, complete a post-test, and complete an evaluation. Proof of completion will be submitted to NABP CPE Monitor.
Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Participants are responsible for verifying credits were transferred successfully to your NABP eProfile account before the ACPE 60-day deadline. After the 60 day deadline, SIDP will no longer be able to report your credit(s) for this activity.
Funding: This activity is provided by SIDP. No external funding was received for this activity.
Disclosures: In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, SIDP asks all individuals involved in the development and presentation of CE activities to disclose all financial relationships with ineligible companies. All relevant financial relationships have been mitigated prior to the CE activity. The following financial relationships have been disclosed:
- Dr. Langford has no relevant financial relationships with an ineligible company to disclose
- Dr. Matukas serves as speaker/advisor/consultant for bioMereiux
- Planning committee - Dr. Melissa Johnson has received research funding from Synexis and royalties/patent beneficiary for Biomeme.
- Presentation title and objectives were written by the planning committee and enhanced by AI. All enhancements were reviewed by a human.
Disclaimer: Faculty members are asked to disclose when any unlabeled/investigational use of pharmaceuticals and devices is being discussed. This activity is intended for educational purposes and should not be used as a substitute for care or advice from a professional. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of SIDP.
The planners and faculty of this continuing education activity have made all reasonable efforts to ensure the accuracy of the information presented in accordance with the latest available scientific knowledge at the time of publication. Healthcare professionals should verify all information and data with recommendations of other authorities before treating patients or employing any therapies described in this continuing education activity.
.gif){kind=logo}